Comments on a Randomized Parallel Non-inferiority Trial to Evaluate the Safety and Efficacy of Levetiracetam in Comparison to Magnesium Sulfate in the Management of Severe Preeclampsia

S Parthasarathy

doi:10.5005/jp-journals-10006-2216

SEARCH WITHIN CONTENT

Online First

Comments on a Randomized Parallel Non-inferiority Trial to Evaluate the Safety and Efficacy of Levetiracetam in Comparison to Magnesium Sulfate in the Management of Severe Preeclampsia

S Parthasarathy

Keywords : Eclampsia, Pregnancy induced hypertension, Premonitory symptoms

Citation Information : Parthasarathy S. Comments on a Randomized Parallel Non-inferiority Trial to Evaluate the Safety and Efficacy of Levetiracetam in Comparison to Magnesium Sulfate in the Management of Severe Preeclampsia. J South Asian Feder Obs Gynae 2023; 15 (2):257-257.

DOI: 10.5005/jp-journals-10006-2216

License: CC BY-NC 4.0

Published Online: 11-05-2023

ARTICLE
REFERENCES

Abstract

HTML PDF Share

Yaliwal RG, Biradar AM, Bhagavati SB, et al. A Randomized parallel non-inferiority trial to evaluate the safety and efficacy of levetiracetam in comparison to magnesium sulfate in the management of severe preeclampsia. J South Asian Feder Obst Gynae 2022;14(3):287–291. DOI: 10.5005/jp-journals-10006-2046.
Anshu, Deepika. Maternal and perinatal outcome in severe pre-eclampsia and eclampsia. J South Asian Feder Obs Gynae 2009;1(3):25–28. DOI: 10.5005/jp-journals-10006-1005.
Vaishnav SB, Raithatha N, Kathawadia K, et al. Making magnesium sulfate therapy safer in eclampsia: A comparative study of zuspan regime vs low-dose intravenous MgSO4 regime. J South Asian Feder Obst Gynae 2019;11(2):126–130. DOI: https://doi.org/10.5005/jp-journals-10006-1675.

PDF Share